-
1
-
-
0025777404
-
Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease
-
2010156 1:STN:280:DyaK3M7osVOisw%3D%3D
-
S Todo AJ Demetris D Van Thiel L Teperman JJ Fung TE Starzl 1991 Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease Hepatology 13 619 626 2010156 1:STN:280:DyaK3M7osVOisw%3D%3D
-
(1991)
Hepatology
, vol.13
, pp. 619-626
-
-
Todo, S.1
Demetris, A.J.2
Van Thiel, D.3
Teperman, L.4
Fung, J.J.5
Starzl, T.E.6
-
2
-
-
0026084824
-
Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis
-
1988336 10.1002/hep.1840130122 1:STN:280:DyaK3M7gs12nuw%3D%3D
-
SE Davies BC Portmann JG O'Grady PM Aldis K Chaggar GJ Alexander R Williams 1991 Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis Hepatology 13 150 157 1988336 10.1002/hep.1840130122 1:STN:280:DyaK3M7gs12nuw%3D%3D
-
(1991)
Hepatology
, vol.13
, pp. 150-157
-
-
Davies, S.E.1
Portmann, B.C.2
O'Grady, J.G.3
Aldis, P.M.4
Chaggar, K.5
Alexander, G.J.6
Williams, R.7
-
3
-
-
0026501529
-
Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications
-
1737910 10.1016/0168-8278(92)90138-F
-
JG O'Grady HM Smith SE Davies HM Daniels PT Donaldson KC Tan B Portmann GJ Alexander R Williams 1992 Hepatitis B virus reinfection after orthotopic liver transplantation. Serological and clinical implications J Hepatol 14 104 111 1737910 10.1016/0168-8278(92)90138-F
-
(1992)
J Hepatol
, vol.14
, pp. 104-111
-
-
O'Grady, J.G.1
Smith, H.M.2
Davies, S.E.3
Daniels, H.M.4
Donaldson, P.T.5
Tan, K.C.6
Portmann, B.7
Alexander, G.J.8
Williams, R.9
-
4
-
-
0034965224
-
A multicenter study of lamivudine treatment in 33 patients with hepatitis B after liver transplantation
-
DOI 10.1053/jlts.2001.24896
-
RJ Fontana HW Hann T Wright G Everson A Baker ER Schiff C Riely G Anschuetz M Riker-Hopkins N Brown Lamivudine Compassionate Use Study Group 2001 A multicenter study of lamivudine treatment in 33 patients with hepatitis B after liver transplantation Liver Transplant 7 6 504 510 10.1053/jlts.2001.24896 1:STN:280:DC%2BD3MzoslGjsw%3D%3D (Pubitemid 32547264)
-
(2001)
Liver Transplantation
, vol.7
, Issue.6
, pp. 504-510
-
-
Fontana, R.J.1
Hann, H.-W.L.2
Wright, T.3
Everson, G.4
Baker, A.5
Schiff, E.R.6
Riely, C.7
Anschuetz, G.8
Riker-Hopkins, M.9
Brown, N.10
-
5
-
-
0031037065
-
Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation
-
DOI 10.1016/S0140-6736(96)02266-0
-
MM Bartholomew RW Jansen LJ Jeffers KR Reddy LC Johnson H Bunzendahl LD Condreay AG Tzakis ER Schiff NA Brown 1997 Hepatitis-B virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation Lancet 349 20 22 8988118 10.1016/S0140-6736(96)02266-0 1:STN:280: DyaK2s7ktFylug%3D%3D (Pubitemid 27022987)
-
(1997)
Lancet
, vol.349
, Issue.9044
, pp. 20-22
-
-
Bartholomew, M.M.1
Jansen, R.W.2
Jeffers, L.J.3
Reddy, K.R.4
Johnson, L.C.5
Bunzendahl, H.6
Condreay, L.D.7
Tzakis, A.G.8
Schiff, E.R.9
Brown, N.A.10
-
6
-
-
0037355283
-
Prevention of and treatment for hepatitis B virus infection after liver transplantation in the nucleoside analogues era
-
DOI 10.1034/j.1600-6143.2003.00063.x
-
GV Papatheodoridis V Sevastianos AK Burroughs 2003 Prevention of and treatment for hepatitis B virus infection after liver transplantation in the nucleoside analogues era Am J Transplant 3 250 258 12614278 10.1034/j.1600-6143. 2003.00063.x 1:CAS:528:DC%2BD3sXjt1ajt74%3D (Pubitemid 36407041)
-
(2003)
American Journal of Transplantation
, vol.3
, Issue.3
, pp. 250-258
-
-
Papatheodoridis, G.V.1
Sevastianos, V.2
Burroughs, A.K.3
-
7
-
-
33947722589
-
Lamivudine monoprophylaxis for liver transplant recipients with non-replicating hepatitis B virus infection
-
DOI 10.1111/j.1399-0012.2006.00557.x
-
H Yoshida T Kato DM Levi A Regev JR Madariaga S Nishida EJ Martinez ER Schiff M Omata AG Tzakis 2007 Lamivudine monoprophylaxis for liver transplant recipients with non-replicating hepatitis B virus infection Clin Transplant 21 166 171 17425740 10.1111/j.1399-0012.2006.00557.x (Pubitemid 46505722)
-
(2007)
Clinical Transplantation
, vol.21
, Issue.2
, pp. 166-171
-
-
Yoshida, H.1
Kato, T.2
Levi, D.M.3
Regev, A.4
Madariaga, J.R.5
Nishida, S.6
Martinez, E.J.7
Schiff, E.R.8
Omata, M.9
Tzakis, A.G.10
-
8
-
-
11144354508
-
Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation
-
DOI 10.1016/j.transproceed.2004.02.025, PII S0041134504001691
-
G Ferretti M Merli S Ginanni Corradini V Callejon P Tanzilli A Masini S Ferretti M Iappelli M Rossi D Rivanera D Lilli C Mancini A Attili P Berloco 2004 Low-dose intramuscular hepatitis B immune globulin and lamivudine for long-term prophylaxis of hepatitis B recurrence after liver transplantation Transplant Proc 36 535 538 15110584 10.1016/j.transproceed.2004.02.025 1:CAS:528: DC%2BD2cXjsVelurY%3D (Pubitemid 38534313)
-
(2004)
Transplantation Proceedings
, vol.36
, Issue.3
, pp. 535-538
-
-
Ferretti, G.1
Merli, M.2
Corradini, S.G.3
Callejon, V.4
Tanzilli, P.5
Masini, A.6
Ferretti, S.7
Iappelli, M.8
Rossi, M.9
Rivanera, D.10
Lilli, D.11
Mancini, C.12
Attili, A.13
Berloco, P.14
-
9
-
-
6444230813
-
Evolving strategies to prevent HBV recurrence
-
DOI 10.1002/lt.20258
-
B Roche D Samuel 2004 Evolving strategies to prevent HBV recurrence Liver Transplant 10 Suppl 2 S74 S85 10.1002/lt.20258 (Pubitemid 39406104)
-
(2004)
Liver Transplantation
, vol.10
, Issue.SUPPL. 2
-
-
Roche, B.1
Samuel, D.2
-
10
-
-
0038363400
-
A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation
-
DOI 10.1016/S0168-8278(03)00087-4
-
M Buti A Mas M Prieto F Casafont A González M Miras JI Herrero R Jardí E Cruz de Castro C García-Rey 2003 A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation J Hepatol 38 811 817 12763375 10.1016/S0168-8278(03)00087-4 1:CAS:528: DC%2BD3sXjvFWnsLo%3D (Pubitemid 36613348)
-
(2003)
Journal of Hepatology
, vol.38
, Issue.6
, pp. 811-817
-
-
Buti, M.1
Mas, A.2
Prieto, M.3
Casafont, F.4
Gonzalez, A.5
Miras, M.6
Herrero, J.-I.7
Jardi, R.8
Cruz De Castro, E.9
Garcia-Rey, C.10
-
11
-
-
2342572873
-
Low-dose hepatitis B immunoglobulin given "on demand" in combination with lamivudine: A highly cost-effective approach to prevent recurrent hepatitis B virus infection in the long-term follow-up after liver transplantation
-
D Di Paolo G Tisone P Piccolo I Lenci S Zazza M Angelico 2004 Low dose hepatitis B immunoglobulin given 'on demand' in combination with lamivudine: a highly cost-effective approach to prevent recurrent hepatitis B virus infection in the long-term follow-up after liver transplantation Transplantation 77 1203 1208 15114086 10.1097/01.TP.0000118904.63669.EB 1:CAS:528:DC%2BD2cXksFOkurw%3D (Pubitemid 38580298)
-
(2004)
Transplantation
, vol.77
, Issue.8
, pp. 1203-1208
-
-
Di Paolo, D.1
Tisone, G.2
Piccolo, P.3
Lenci, I.4
Zazza, S.5
Angelico, M.6
-
12
-
-
19944397810
-
Low-dose hepatitis B immune globulin and higher-dose lamivudine combination to prevent hepatitis B virus recurrence after liver transplantation
-
Z Karasu T Ozacar M Akyildiz T Demirbas C Arikan A Kobat U Akarca G Ersoz F Gunsar Y Batur M Kilic Y Tokat 2004 Low-dose hepatitis B immune globulin and higher-dose lamivudine combination to prevent hepatitis B virus recurrence after liver transplantation Antivir Ther 9 921 927 15651751 1:CAS:528: DC%2BD2MXhtFahtb0%3D (Pubitemid 40040266)
-
(2004)
Antiviral Therapy
, vol.9
, Issue.6
, pp. 921-927
-
-
Karasu, Z.1
Ozacar, T.2
Akyildiz, M.3
Demirbas, T.4
Arikan, C.5
Kobat, A.6
Akarca, U.7
Ersoz, G.8
Gunsar, F.9
Batur, Y.10
Kilic, M.11
Tokat, Y.12
-
13
-
-
33846587003
-
Short-term high-dose followed by long-term low-dose hepatitis B immunoglobulin and lamivudine therapy prevented recurrent hepatitis B after liver transplantation
-
DOI 10.1097/01.tp.0000246310.75638.86, PII 0000789020070127000016
-
A Takaki T Yagi Y Iwasaki H Sadamori H Matsukawa H Matsuda S Shinoura Y Umeda Y Miyake R Terada H Kobashi K Sakaguchi N Tanaka Y Shiratori 2007 Short-term high-dose followed by long-term low-dose hepatitis B immunoglobulin and lamivudine therapy prevented recurrent hepatitis B after liver transplantation Transplantation 83 231 233 17264822 10.1097/01.tp.0000246310. 75638.86 1:CAS:528:DC%2BD2sXhtVyisrs%3D (Pubitemid 46185216)
-
(2007)
Transplantation
, vol.83
, Issue.2
, pp. 231-233
-
-
Takaki, A.1
Yagi, T.2
Iwasaki, Y.3
Sadamori, H.4
Matsukawa, H.5
Matsuda, H.6
Shinoura, S.7
Umeda, Y.8
Miyake, Y.9
Terada, R.10
Kobashi, H.11
Sakaguchi, K.12
Tanaka, N.13
Shiratori, Y.14
-
14
-
-
0037785048
-
HBV DNA persistence 10 years after liver transplantation despite successful anti-HBs passive immunoprophylaxis
-
DOI 10.1053/jhep.2003.50294
-
B Roche C Feray M Gigou AM Roque-Afonso JL Arulnaden V Delvart E Dussaix C Guettier H Bismuth D Samuel 2003 HBV DNA persistence 10 years after liver transplantation despite successful anti-HBS passive immunoprophylaxis Hepatology 38 1 86 95 12829990 10.1053/jhep.2003.50294 (Pubitemid 36775799)
-
(2003)
Hepatology
, vol.38
, Issue.1
, pp. 86-95
-
-
Roche, B.1
Feray, C.2
Gigou, M.3
Roque-Afonso, A.M.4
Arulnaden, J.L.5
Delvart, V.6
Dussaix, E.7
Guettier, C.8
Bismuth, H.9
Samuel, D.10
-
15
-
-
0036159549
-
Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load
-
DOI 10.1128/JCM.40.2.439-445.2002
-
T Kimura A Rokuhara Y Sakamoto S Yagi E Tanaka K Kiyosawa N Maki 2002 Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load J Clin Microbiol 40 439 445 11825954 10.1128/JCM.40.2.439-445.2002 1:CAS:528:DC%2BD38XhvFGktbk%3D (Pubitemid 34130865)
-
(2002)
Journal of Clinical Microbiology
, vol.40
, Issue.2
, pp. 439-445
-
-
Kimura, T.1
Rokuhara, A.2
Sakamoto, Y.3
Yagi, S.4
Tanaka, E.5
Kiyosawa, K.6
Maki, N.7
-
16
-
-
20444443547
-
Hepatitis B virus DNA-negative dane particles lack core protein but contain a 22-kDa precore protein without C-terminal arginine-rich domain
-
DOI 10.1074/jbc.M501564200
-
T Kimura N Ohno N Terada A Rokuhara A Matsumoto S Yagi E Tanaka K Kiyosawa S Ohno N Maki 2005 Hepatitis B virus DNA-negative Dane particles lack core protein but contain a 22-kDa precore protein without C-terminal arginine-rich domain J Biol Chem 280 21713 21719 15814524 10.1074/jbc.M501564200 1:CAS:528:DC%2BD2MXksl2iur0%3D (Pubitemid 40827817)
-
(2005)
Journal of Biological Chemistry
, vol.280
, Issue.23
, pp. 21713-21719
-
-
Kimura, T.1
Ohno, N.2
Terada, N.3
Rokuhara, A.4
Matsumoto, A.5
Yagi, S.6
Tanaka, E.7
Kiyosawa, K.8
Ohno, S.9
Maki, N.10
-
17
-
-
58149250976
-
Correlation between serum hepatitis B virus core-related antigen and intrahepatic covalently closed circular DNA in chronic hepatitis B patients
-
19031469 10.1002/jmv.21339
-
F Suzuki H Miyakoshi M Kobayashi H Kumada 2009 Correlation between serum hepatitis B virus core-related antigen and intrahepatic covalently closed circular DNA in chronic hepatitis B patients J Med Virol 81 27 33 19031469 10.1002/jmv.21339
-
(2009)
J Med Virol
, vol.81
, pp. 27-33
-
-
Suzuki, F.1
Miyakoshi, H.2
Kobayashi, M.3
Kumada, H.4
-
18
-
-
2942532722
-
Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy
-
DOI 10.1053/j.gastro.2004.03.018
-
B Werle-Lapostolle S Bowden S Locarnini K Wursthorn J Petersen G Lau C Trepo P Marcellin Z Goodman WE Delaney 4th S Xiong CL Brosgart SS Chen CS Gibbs F Zoulim 2004 Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy Gastroenterology 126 1750 1758 15188170 10.1053/j.gastro.2004.03.018 1:CAS:528:DC%2BD2cXlsFaqs78%3D (Pubitemid 38736340)
-
(2004)
Gastroenterology
, vol.126
, Issue.7
, pp. 1750-1758
-
-
Werle-Lapostolle, B.1
Bowden, S.2
Locarnini, S.3
Wursthorn, K.4
Petersen, J.5
Lau, G.6
Trepo, C.7
Marcellin, P.8
Goodman, Z.9
Delaney IV, W.E.10
Xiong, S.11
Brosgart, C.L.12
Chen, S.-S.13
Gibbs, C.S.14
Zoulim, F.15
-
19
-
-
0025787396
-
Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization
-
1918881 10.1016/0168-8278(91)90869-D
-
R Müller G Gubernatis M Farle G Niehoff H Klein C Wittekind G Tusch HU Lautz K Böker W Stangel 1991 Liver transplantation in HBs antigen (HBsAg) carriers. Prevention of hepatitis B virus (HBV) recurrence by passive immunization J Hepatol 13 90 96 1918881 10.1016/0168-8278(91)90869-D
-
(1991)
J Hepatol
, vol.13
, pp. 90-96
-
-
Müller, R.1
Gubernatis, G.2
Farle, M.3
Niehoff, G.4
Klein, H.5
Wittekind, C.6
Tusch, G.7
Lautz, H.U.8
Böker, K.9
Stangel, W.10
-
20
-
-
0027369425
-
Liver transplantation in European patients with the hepatitis B surface antigen
-
DOI 10.1056/NEJM199312163292503
-
D Samuel R Muller G Alexander L Fassati B Ducot JP Benhamou H Bismuth 1993 Liver transplantation in European patients with the hepatitis B surface antigen N Engl J Med 329 1842 1847 8247035 10.1056/NEJM199312163292503 1:STN:280:DyaK2c%2Fmslaisw%3D%3D (Pubitemid 23360483)
-
(1993)
New England Journal of Medicine
, vol.329
, Issue.25
, pp. 1842-1847
-
-
Samuel, D.1
Muller, R.2
Alexander, G.3
Fassati, L.4
Ducot, B.5
Benhamou -, J.P.6
Bismuth, H.7
Casanovas, T.8
Jaurrieta, E.9
Blumhardt, G.10
Neuhaus, P.11
Neuberger, J.12
McMaster, P.13
Saric, J.14
Winnock, S.15
Lerut, J.16
Otte, B.17
Alexander, G.18
Calne, R.Y.19
-
21
-
-
16044367618
-
Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis
-
DOI 10.1016/S0140-6736(96)04444-3
-
L Grellier D Mutimer M Ahmed D Brown AK Burroughs K Rolles P McMaster P Beranek F Kennedy H Kibbler P McPhillips E Elias G Dusheiko 1996 Lamivudine prophylaxis against reinfection in liver transplantation for hepatitis B cirrhosis Lancet 348 1212 1215 8898039 10.1016/S0140-6736(96)04444-3 1:STN:280:DyaK2s%2FltlGhtQ%3D%3D (Pubitemid 26361609)
-
(1996)
Lancet
, vol.348
, Issue.9036
, pp. 1212-1215
-
-
Grellier, L.1
Mutimer, D.2
Ahmed, M.3
Brown, D.4
Burroughs, A.K.5
Rolles, K.6
McMaster, P.7
Beranek, P.8
Kennedy, F.9
Kibbler, H.10
McPhillips, P.11
Elias, E.12
Dusheiko, G.13
-
22
-
-
17344364991
-
Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin
-
DOI 10.1002/hep.510280241
-
JS Markowitz P Martin AJ Conrad JF Markmann P Seu H Yersiz JA Goss P Schmidt A Pakrasi L Artinian NG Murray DK Imagawa C Holt LI Goldstein R Stribling RW Busuttil 1998 Prophylaxis against hepatitis B recurrence following liver transplantation using combination lamivudine and hepatitis B immune globulin Hepatology 28 585 589 9696028 10.1002/hep.510280241 1:STN:280:DyaK1czlvFWquw%3D%3D (Pubitemid 28363690)
-
(1998)
Hepatology
, vol.28
, Issue.2
, pp. 585-589
-
-
Markowitz, J.S.1
Martin, P.2
Conrad, A.J.3
Markmann, J.F.4
Seu, P.5
Yersiz, H.6
Goss, J.A.7
Schmidt, P.8
Pakrasi, A.9
Artinian, L.10
Murray, N.G.B.11
Imagawa, D.K.12
Holt, C.13
Goldstein, L.I.14
Stribling, R.15
Busuttil, R.W.16
-
23
-
-
34548168797
-
Presence of intrahepatic (total and ccc) HBV DNA is not predictive of HBV recurrence after liver transplantation
-
DOI 10.1002/lt.21179
-
M Hussain C Soldevila-Pico S Emre V Luketic AS Lok NIH HBV-OLT Study Group 2007 Presence of intrahepatic (total and ccc) HBV DNA is not predictive of HBV recurrence after liver transplantation Liver Transplant 13 8 1137 1144 10.1002/lt.21179 (Pubitemid 47305032)
-
(2007)
Liver Transplantation
, vol.13
, Issue.8
, pp. 1137-1144
-
-
Hussain, M.1
Soldevila-Pico, C.2
Emre, S.3
Luketic, V.4
Lok, A.S.F.5
-
24
-
-
33748929265
-
Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B
-
DOI 10.1002/hep.21282
-
K Wursthorn M Lutgehetmann M Dandri T Volz P Buggisch B Zollner T Longerich P Schirmacher F Metzler M Zankel C Fischer G Currie C Brosgart J Petersen 2006 Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B Hepatology 44 675 684 16941693 10.1002/hep.21282 1:CAS:528:DC%2BD28XhtVeqt7bM (Pubitemid 44433724)
-
(2006)
Hepatology
, vol.44
, Issue.3
, pp. 675-684
-
-
Wursthorn, K.1
Lutgehetmann, M.2
Dandri, M.3
Volz, T.4
Buggisch, P.5
Zollner, B.6
Longerich, T.7
Schirmacher, P.8
Metzler, F.9
Zankel, M.10
Fischer, C.11
Currie, G.12
Brosgart, C.13
Petersen, J.14
-
25
-
-
20444505037
-
Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy
-
DOI 10.1053/j.gastro.2005.03.009, PII S0016508505003902
-
JJ Sung ML Wong S Bowden CT Liew AY Hui VW Wong NW Leung S Locarnini HL Chan 2005 Intrahepatic hepatitis B virus covalently closed circular DNA can be a predictor of sustained response to therapy Gastroenterology 128 1890 1897 15940624 10.1053/j.gastro.2005.03.009 1:CAS:528:DC%2BD2MXlvFKlsLc%3D (Pubitemid 40824700)
-
(2005)
Gastroenterology
, vol.128
, Issue.7
, pp. 1890-1897
-
-
Sung, J.J.Y.1
Wong, M.-L.2
Bowden, S.3
Liew, C.-T.4
Hui, A.Y.5
Wong, V.W.S.6
Leung, N.W.Y.7
Locarnini, S.8
Chan, H.L.Y.9
-
26
-
-
0038276960
-
Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: Analysis and review of the literature
-
DOI 10.1053/jhep.2003.50208
-
H Mommeja-Marin E Mondou MR Blum F Rousseau 2003 Serum HBV DNA as a marker of efficacy during therapy for chronic HBV infection: analysis and review of the literature Hepatology 37 1309 1319 12774009 10.1053/jhep.2003.50208 (Pubitemid 36667310)
-
(2003)
Hepatology
, vol.37
, Issue.6
, pp. 1309-1319
-
-
Mommeja-Marin, H.1
Mondou, E.2
Blum, M.R.3
Rousseau, F.4
-
27
-
-
0030776176
-
Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus
-
G Moraleda J Saputelli CE Aldrich D Averett L Condreay WS Mason 1997 Lack of effect of antiviral therapy in nondividing hepatocyte cultures on the closed circular DNA of woodchuck hepatitis virus J Virol 71 9392 9399 9371599 1:CAS:528:DyaK2sXnsVCktLw%3D (Pubitemid 27492382)
-
(1997)
Journal of Virology
, vol.71
, Issue.12
, pp. 9392-9399
-
-
Moraleda, G.1
Saputelli, J.2
Aldrich, C.E.3
Averett, D.4
Condreay, L.5
Mason, W.S.6
-
28
-
-
0033988351
-
Characterization of the antiviral effect of 2',3'-dideoxy-2', 3'- didehydro-β-L-5-fluorocytidine in the duck hepatitis B virus infection model
-
F Le Guerhier C Pichoud S Guerret M Chevallier C Jamard O Hantz XY Li SH Chen I King C Trépo YC Cheng F Zoulim 2000 Characterization of the antiviral effect of 2, 3-dideoxy-2, 3-didehydro-beta-l-5-fluorocytidine in the duck hepatitis B virus infection model Antimicrob Agents Chemother 44 111 122 10602731 10.1128/AAC.44.1.111-122.2000 1:CAS:528:DC%2BD3cXhtFCmsg%3D%3D (Pubitemid 30010680)
-
(2000)
Antimicrobial Agents and Chemotherapy
, vol.44
, Issue.1
, pp. 111-122
-
-
Le Guerhier, F.1
Pichoud, C.2
Guerret, S.3
Chevallier, M.4
Jamard, C.5
Hantz, O.6
Li, X.-Y.7
Chen, S.-H.8
King, I.9
Trepo, C.10
Cheng, Y.-C.11
Zoulim, F.12
-
29
-
-
0032565689
-
Lamivudine therapy of WHV-infected woodchucks
-
DOI 10.1006/viro.1998.9150
-
WS Mason J Cullen G Moraleda J Saputelli CE Aldrich DS Miller B Tennant L Frick D Averett LD Condreay AR Jilbert 1998 Lamivudine therapy of WHV-infected woodchucks Virology 245 18 32 9614864 10.1006/viro.1998.9150 1:CAS:528:DyaK1cXjsFWgur0%3D (Pubitemid 28384074)
-
(1998)
Virology
, vol.245
, Issue.1
, pp. 18-32
-
-
Mason, W.S.1
Cullen, J.2
Moraleda, G.3
Saputelli, J.4
Aldrich, C.E.5
Miller, D.S.6
Tennant, B.7
Frick, L.8
Averett, D.9
Condreay, L.D.10
Jilbert, A.R.11
-
30
-
-
20244368202
-
Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence
-
DOI 10.1002/lt.20402
-
A Marzano S Gaia V Ghisetti S Carenzi A Premoli W Debernardi-Venon C Alessandria A Franchello M Salizzoni M Rizzetto 2005 Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence Liver Transplant 11 4 402 409 10.1002/lt.20402 (Pubitemid 40533208)
-
(2005)
Liver Transplantation
, vol.11
, Issue.4
, pp. 402-409
-
-
Marzano, A.1
Gaia, S.2
Ghisetti, V.3
Carenzi, S.4
Premoli, A.5
Debernardi-Venon, W.6
Alessandria, C.7
Franchello, A.8
Salizzoni, M.9
Rizzetti, M.10
-
31
-
-
33846079661
-
Outcomes of Hepatitis B Virus Recurrence After Liver Transplantation
-
DOI 10.1016/j.transproceed.2006.06.032, PII S0041134506006506
-
YS Han SK Lee JW Joh SJ Kim CH Kwon JW Park DJ Kim JB Park 2006 Outcomes of hepatitis B virus recurrence after liver transplantation Transplant Proc 38 7 2123 2124 16980019 10.1016/j.transproceed.2006.06.032 1:STN:280: DC%2BD28rlsFClug%3D%3D (Pubitemid 46068478)
-
(2006)
Transplantation Proceedings
, vol.38
, Issue.7
, pp. 2123-2124
-
-
Han, Y.S.1
Lee, S.-K.2
Joh, J.W.3
Kim, S.J.4
Kwon, C.H.D.5
Park, J.W.6
Kim, D.J.7
Park, J.B.8
|